Steven M Paul's Net Worth

Steven M Paul's net worth is estimated to be at least $71,536,395.30 as of 10/01/2022. CoreStreet's estimation of Steven M Paul's net worth is based on their sale of stock and current holding of stock.

Steven M Paul is Director at Alnylam Pharmaceuticals Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,000 units of ALNY stock on 04/01/2022. Their biggest sale was on 06/29/2020 when they sold 292,207 units of Karuna Therapeutics Inc stock for $30,243,424.50. They typically trade 2 times per year.

Total value of insider buys:
  • $591,060.29
Total value of insider sells:
  • $70,945,335.01
Most recent insider trade:
  • April 1, 2022

Steven M Paul's Insider Trading History

Alnylam Pharmaceuticals IncTitleAmountPriceTypeTotal Value
April 1, 2022
Director15,000$170.69Sell$2,560,350.00
Dec. 18, 2020
Director15,000$140.00Sell$2,100,000.00
Feb. 10, 2020
Director30,000$130.00Sell$3,900,000.00
Jan. 26, 2015
Director1,000$95.00Buy$95,000.00
Karuna Therapeutics IncTitleAmountPriceTypeTotal Value
Aug. 17, 2021
CEO1,183$105.63Buy$124,960.29
June 29, 2020
CEO292,207$103.50Sell$30,243,424.50
June 28, 2019
CEO10,000$23.04Buy$230,400.00
Sage TherapeuticTitleAmountPriceTypeTotal Value
March 20, 2019
Director60,421$161.28Sell$9,744,698.88
March 18, 2019
Director3,775$161.05Sell$607,963.75
March 1, 2019
Director2,600$161.00Sell$418,600.00
Feb. 25, 2019
Director2,000$161.00Sell$322,000.00
Feb. 19, 2019
Director1,543$161.62Sell$249,379.66
Feb. 15, 2019
Director49,461$161.02Sell$7,964,210.22
March 6, 2018
Director58,139$172.00Sell$9,999,908.00
July 1, 2015
Director20,000$69.40Sell$1,388,000.00
June 1, 2015
Director20,000$72.34Sell$1,446,800.00
Voyager Therapeutics IncTitleAmountPriceTypeTotal Value
Jan. 14, 2016
CEO10,000$14.07Buy$140,700.00